BioSpace News Archive

Drug Development

Novo Takes Aim at Lilly’s Zepbound in Head-to-Head Trial Versus Wegovy Combo

Just a week after it secured FDA approval, Eli Lilly’s Zepbound now faces a challenge from Novo Nordisk’s investigational next-generation weight-loss candidate CagriSema in a Phase III trial.

November 16, 2023
·
2 min read
·
Tristan Manalac
FDA

CorMedix Wins FDA Approval for Antimicrobial Drug Combo After Two Rejections

Approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs, CorMedix’s DefenCath reduces the incidence of catheter-related bloodstream infections in adult hemodialysis patients.

November 16, 2023
·
2 min read
·
Tristan Manalac
Policy

Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK

The U.K.’s Medicines and Healthcare products Regulatory Agency on Thursday provided conditional marketing authorization for Vertex Pharmaceuticals and CRISPR Therapeutics’ gene-edited therapy exa-cel.

November 16, 2023
·
2 min read
·
Tristan Manalac
Drug Development

5 Cancer Vaccines to Watch in 2024

BioSpace takes a deep dive into five investigational therapeutic cancer vaccines that have recently shown efficacy in difficult-to-treat indications.

November 16, 2023
·
6 min read
·
Sruthi S. Balakrishnan
FDA

BMS Drug Augtyro Gets FDA Approval to Treat ROS1-Positive NSCLC

After Bristol Myers Squibb picked up Augtyro as part of its $4.1 billion takeover of Turning Point Therapeutics last year, the ROS1-positive non-small cell lung cancer drug reached the regulatory finish line on Wednesday.

November 16, 2023
·
2 min read
·
Tyler Patchen
Drug Development

Astellas Sees Path Forward for Gene Therapy Despite Four Patient Deaths

The Japanese pharma contends that an analysis of the four deaths in its AT132 gene therapy clinical trial shows it is still viable as a potential treatment for a fatal, rare genetic disease.

November 16, 2023
·
2 min read
·
Kate Goodwin
Business

RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.

RenovoRx, Inc today announced the appointment of Michel Ducreux, M.D., Ph.D. to the Company’s Scientific Advisory Board (SAB).

November 16, 2023
·
8 min read
Deals

CEL-SCI Announces Pricing of $5 Million Offering of Common Stock

CEL-SCI Corporation today announced the pricing of an offering of 2,490,000 shares of its common stock to a single investor at an offering price of $2.00 per share, for gross proceeds of approximately $5 million, before deducting underwriting discounts and offering expenses.

November 16, 2023
·
4 min read
Pharm Country

Children’s Hospital of Philadelphia Receives Multi-Million Dollar Gift from Holveck Family to Support Groundbreaking Osteosarcoma Research

Children’s Hospital of Philadelphia has received a $6.4 million gift from the family of Connor Boyle, a Central Bucks East High School graduate who died at age 18 from osteosarcoma.

November 16, 2023
·
4 min read
BioMidwest

InnerScope Hearing Technologies (OTC:INND) Launches its iHEAR Matrix OTC Hearing Aids in 4218 Walmart Stores

InnerScope Hearing Technologies Inc. announced it is launching the iHEAR Matrix Rechargeable OTC Hearing Aids with Walmart as part of Walmart’s OTC hearing aid display fixture located in 4,218 Walmart stores nationwide.

November 16, 2023
·
7 min read